drugset / Trial / NCT00001057

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

NCT00001057

Treatment

Summary

To determine the effects of zidovudine (AZT) alone and in combination with didanosine (ddI) on viral load in the lymphoid tissue and blood of antiretroviral-naive, HIV-infected patients with CD4 counts greater than or equal to 550 cells/mm3. Recent studies have shown that during the asymptomatic phase (clinical latency) of HIV infection, there is an extraordinarily large number of infected CD4+ lymphocytes and macrophages throughout the lymphoid system, both in latent and productive states. These findings support the belief that early intervention therapy with reverse transcriptase inhibitors could prolong the clinical latency period.

Timeline

Start
Primary completion
Completion
1995-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Didanosine Small molecule
Subject Zidovudine Small molecule